1Breedveld FC. Tumour necrosis factor antagonists: Infliximab, adalimumab and etanercepr [J]: Nededands Tijdschriftvoor Genecskunde, 2005, 149(41):2273-2277.
2Clelland S, Hunek JR. Etanercept injection site reaction[J]. Dermatology Nursing, 2005,17(5):375.
3Haraoui B, Differentiating the efficacy of tumor necrosis factor inhibitors [J]. Journal of Rheumatology Supplement, 2005,74:3-7.
4Soliotis F, Glover M, Jawad AS. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis [J]. Annals of the Rheumatic Diseases,2002,61(9):850-851.
5Rita Bunikowski, Kerstin Gerhold,Matthias Brautigem, et al. Effect of low-dose cyclosporin A microemulsionon disease severity, interleukin-6, imerleukin-8 nd tumor necrosis factor alpha production in severe pediatric atopic dermatitis [J]. Internationl Archives of Allergy and Immunology,2001,125(4):344-348.
6Leonardo H Tonelli, Teodor T Postolache. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge [J]. Neurlogical Research, 2005,27(7): 679-684.
